论文期刊

取消

高级检索

检索历史清除

首页> Frontiers in immunology> Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.

Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.

导出 LinkOut

翻译打印收藏纠错

作者： Lydia,Lee ^[1] ; Nouf,Alrasheed ^[1] ; Garima,Khandelwal ^[2] ; Evelyn,Fitzsimons ^[1] ; Huw,Richards ^[1] ; William,Wilson ^[3] ; Selina J,Chavda ^[1] ; Jake,Henry ^[1] ; Lucia,Conde ^[4] ; Marc Robert,De Massy ^[2] ; Melody,Chin ^[1] ; Daria,Galas-Filipowicz ^[4] ; Javier,Herrero ^[5] ; Benny,Chain ^[1] ; Sergio A,Quezada ^[1] ; Kwee,Yong ^[2]

作者单位： Research Department of Hematology, Cancer Institute, University College London, London, United Kingdom. ^[1] Bill Lyons Informatics Centre, Cancer Institute, University College London, London, United Kingdom. ^[2] Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom. ^[3] Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London, United Kingdom. ^[4] Department of Immunology, University College London, London, United Kingdom. ^[5]

关键词 Ki-67 PD-1 T cell receptor autologous stem cell transplant immune phenotype multiple myeloma

主题词女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴细胞计数(Lymphocyte Count);男(雄)性(Male);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);预后(Prognosis);受体, 免疫(Receptors, Immunologic);T淋巴细胞亚群(T-Lymphocyte Subsets);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)

DOI 10.3389/fimmu.2021.618610

PMID 33717112

发布时间 2024-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in immunology

618610页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Frontiers in immunology

618610页

相关期刊

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷